Benralizumab-induced asthma remission: evidence from the real- world imPROve study

被引：0
|
作者：
Lommatzsch, M. [1 ]
Korn, S. [2 ]
Grund, T. [3 ]
Emmanuel, B. [4 ]
Shavit, A. [5 ]
Plate, T. [3 ]
Saathoff, M. [6 ]
Watz, H. [7 ]
机构：
[1] Univ Med Ctr Rostock, Pulmonol Interdisciplinary Icu, Rostock, Germany
[2] Clin Res Ctr Resp Dis Ikf, Mainz, Germany
[3] Astrazeneca, Biopharmaceut Med, Hamburg, Germany
[4] Astrazeneca, Biopharmaceut Med, Gaithersburg, MD USA
[5] Astrazeneca, Biopharmaceut Med, Cambridge, England
[6] Alcedis, Giessen, Germany
[7] German Ctr Lung Res Dzl, Lungenclin Grosshansdorf, Pulm Res Inst, Airway Res Ctr North Arcn, Grosshansdorf, Germany
来源：
PNEUMOLOGIE | 2023年 / 77卷
关键词：
D O I：
10.1055/s-0043-1761049
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
Po 328
引用
收藏
页码：S76 / S77
页数：2
相关论文
共 50 条
  • [1] Benralizumab-induced asthma remission: evidence from the real-world imPROve study
    Lommatzsch, M.
    Korn, S.
    Grund, T.
    Emmanuel, B.
    Shavit, A.
    Plate, T.
    Saathoff, M.
    Watz, H.
    ALLERGOLOGIE, 2022, 45 (08) : 615 - 615
  • [2] Durability of Benralizumab-induced remission in severe asthma: an analysis of the BORA study
    Lommatzsch, Marek
    Shavit, Anat
    Bourdin, Anaud
    Kwiatek, Justin
    Cohen, David
    Leynaud, Delphine
    Menzies-Gow, Andrew
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [3] Episodic angioedema associated with eosinophilia: Benralizumab-induced complete remission
    Gleich, Gerald J.
    Hendershot, Richard
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2024, 12 (01): : 259 - 261
  • [4] Early response and remission with benralizumab in patients with severe asthma and chronic rhinosinusitis with nasal polyposis ( CRSwNP) in the prospective real-world imPROve Asthma study
    Korn, S.
    Watz, H.
    Emmanuel, B.
    Plate, T.
    Saathoff, M.
    Shavit, A.
    Grund, T.
    Lommatzsch, M.
    PNEUMOLOGIE, 2023, 77 : S76 - S76
  • [5] Early response and remission with benralizumab in patients with severe asthma and chronic rhinosinusitis with nasal polyposis (CRSwNP) in the prospective real-world ImPROve Asthma study
    Korn, S.
    Watz, H.
    Emmanuel, B.
    Plate, T.
    Saathoff, M.
    Shavit, A.
    Grund, T.
    Lommatzsch, M.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [6] Real-world clinical remission of severe asthma with benralizumab in Spanish adults with severe asthma
    Martinez-Moragon, Eva
    Chiner, Eusebi
    Mogrovejo, Alexandra Suliana
    Cervera, Marta Palop
    Tortajada, Inmaculada Lluch
    Enrique, Ignacio Boira
    Vera, Andres Fernando Sanchez
    JOURNAL OF ASTHMA, 2024, 61 (10) : 1190 - 1204
  • [7] Asthma Clinical Remission with Benralizumab in an Integrated Analysis of the Real-World XALOC-1 Study
    Jackson, David
    Pelaia, Girolamo
    Padilla-Galo, Alicia
    Watt, Michael
    Kayaniyil, Sheena
    Boarino, Silvia
    Sanchez Tena, Jesus
    Shih, Vivian
    Tran, Trung
    Arbetter, Douglas
    Cohen, David
    Katial, Rohit
    Kwiatek, Justin
    Shavit, Anat
    Emmanuel, Benjamin
    Nair, Parameswaran
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB13 - AB13
  • [8] A real-world analysis of key asthma remission components in patients treated with benralizumab: the ZEPHYR-4 study
    Carstens, Donna
    Ojeranti, Daniel
    Chung, Yen
    Chan, K. Arnold
    Dhopeshwarkar, Neil
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB99 - AB99
  • [9] Real-World Effectiveness of Benralizumab on Asthma Exacerbations: Results from the ZEPHYR 1 Study
    Carstens, D. D.
    Katial, R.
    Young, J.
    Cook, E. E.
    Mu, F.
    Betts, K. A.
    Yang, D.
    Chung, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [10] Overcoming Barriers to Remission in Severe Eosinophilic Asthma: Two-Year Real-World Data With Benralizumab
    Jackson, David J.
    Burhan, Hassan
    Rupani, Hitasha
    Pfeffer, Paul E.
    Clifton, Ian J.
    Faruqi, Shoaib
    Dhariwal, Jaideep
    Patel, Pujan
    Morris, Tamsin
    Lipworth, Joseph
    Watt, Michael
    Lupton, Charlotte
    Dube, Sabada
    Hickey, Joe
    Nanzer, Alexandra M.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2024, 54 (10): : 734 - 746
12345